Aurobindo Pharma's subsidiary Eugia Pharma Specialities received a warning letter from the USFDA concerning its formulations manufacturing ...

The affected lot of the medication, which is used to treat high blood pressure, has been manufactured in India and marketed in the US marke...

The market regulator, in its letter to Aurobindo Pharma dated June 24, said the company had disclosed very limited and restricted informati...

Aurobindo’s scrip fell to a low of Rs 612.60, 2 per cent lower than previous close on the National Stock Exchange, while Sun Pharma’s count...

According to the latest enforcement report issued by the US Food and Drug Administration (USFDA), the US-based arm of Aurobindo Pharma is r...

As per the USFDA, a VAI inspection classification indicates that although investigators found and documented objectionable conditions durin...

According to USFDA's definitions, OAI means "objectionable conditions were found and regulatory administrative sanctions by FDA are indicat...

Quoting IQVIA data, Aurobindo Pharma said the approved product has an estimated market size of USD 11 million for the 12 months ending Sept...

"The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture Ibuprofen capsules OTC, 200 mg," P...

Aurobindo Pharma has received tentative approval from the USFDA for dolutegravir, lamivudine and tenofovir disoproxil fumarate tablets, use...

"The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Fenofibrate Tablets, 48 m...

Drug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market Ibandronate Sodium tablets, in the American mar...

Aurobindo Pharma received approval from the USFDA to manufacture and market generic version of Pfizer's Revatio tablets used in the treatme...

This ANDA is at present under litigation in the United States District Court for the District of Delaware, Aurobindo Pharma said.

USFDA has lifted the import alert for non-sterile products manufactured at Unit-VI cephalosporin facility based in Hyderabad.

Aurobindo Pharma said it has received a warning letter from the USFDA with regard to its antibiotics manufacturing unit in Hyderabad.

Aurobindo Pharma today said it has received a warning letter from the US health regulator with regard to its antibiotics manufacturing unit...